ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "32115b12-5d6f-49f2-973d-4569c421b1ab"}, "_deposit": {"id": "2016290", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "2016290"}, "status": "published"}, "_oai": {"id": "oai:u-ryukyu.repo.nii.ac.jp:02016290", "sets": ["1642838247989", "1642838412624"]}, "author_link": [], "item_1617186331708": {"attribute_name": "Title", "attribute_value_mlt": [{"subitem_1551255647225": "[原著]SLE の血液透析療法", "subitem_1551255648112": "ja"}, {"subitem_1551255647225": "Hemodialysis treatment of SLE", "subitem_1551255648112": "en"}]}, "item_1617186419668": {"attribute_name": "Creator", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "大浦, 孝", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "佐久本, 政紀", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "三村, 悟郎", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "宮里, 不二彦", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "山口, 栄豊", "creatorNameLang": "ja"}]}, {"creatorNames": [{"creatorName": "Oura, Takashi", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Sakumoto, Seiki", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Mimura, Goro", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Miyasato, Fuzihiko", "creatorNameLang": "en"}]}, {"creatorNames": [{"creatorName": "Yamaguchi, Eiho", "creatorNameLang": "en"}]}]}, "item_1617186476635": {"attribute_name": "Access Rights", "attribute_value_mlt": [{"subitem_1522299639480": "open access", "subitem_1600958577026": "http://purl.org/coar/access_right/c_abf2"}]}, "item_1617186499011": {"attribute_name": "Rights", "attribute_value_mlt": [{"subitem_1522650717957": "ja", "subitem_1522651041219": "琉球医学会"}]}, "item_1617186626617": {"attribute_name": "Description", "attribute_value_mlt": [{"subitem_description": "Dialysis treatment is developing every year and it\u0027s indication is becoming very wide. For example, now it is possible to treat chronic renal failure (CRF) due to diabetes mellitus or systemic lupus erythematosus (SLE) by hemodialysis. But there are many troubles during hemodialysis treatment of these diseases. We experienced 3 cases of SLE, which developed CRF and hemodialysis was introduced. We describe the clinical course of pre-dialysis and post-dialysis, and discuss the specific problems of SLE during hemodialysis. Case 1, 27 year old, female, the onset was at age 18, nephrotic syndrome was complicated after 7 years, then corticosteroid therapy was strted but after one year she rejected our therapy and changed to the so-called traditional vacuum therapy. Soon after she returned to our clinics, by then she was in terminal stage of disease, namely CRF and chronic heart failure. Peritoneal dialysis was strted and then maintenance hemodialysis was introduced. The clinical course of post-hemodialysis was uneventful. There were no specific problems during hemodialysis and it was possible to rehabilitate. Case 2, 19 year old, female, the onset was at age 15, nephrotic syndrome was complicated. Corticosteroid therapy was strted, but she developed CRF 4 years after the onset. Occational high fever appeared during hemodialysis, and infection was suspected. Unfortunately she died 2 months after beginning hemodialysis due to cerebro-vascular accident (CVA). Case 3, 45 year old, female, the onset was at age 31. She suffered from many complications, such as epilepsy, aseptic necrosis of femoral head and urinary tract infection. Lupus nephritis gradully progressed to CRF over 10 years. After beginning hemodialysis she suffered from G-1 bleeding and accelerated hypertension so rehavilitation was difficult until now. We discuss some problems during hemodialysis of SLE. Infection was the ploblem in case 2 and CVA was attributable to bleeding tndency, which is one of the symptoms of SLE, and may be exacervated by using heparin during hemodialysis. G-1 bleeding and accelerated hypertension were the problems in case 3. There were some problems during hemodialysis of SLE, but it is possible to control CRF due to SLE by hemodialysis such as case 1, so we should try many more case of SLE to solve these problems.", "subitem_description_type": "Other"}, {"subitem_description": "論文", "subitem_description_type": "Other"}]}, "item_1617186643794": {"attribute_name": "Publisher", "attribute_value_mlt": [{"subitem_1522300295150": "ja", "subitem_1522300316516": "琉球大学保健学部"}, {"subitem_1522300295150": "en", "subitem_1522300316516": "College of Health Sciences, University of the Ryukyus"}]}, "item_1617186702042": {"attribute_name": "Language", "attribute_value_mlt": [{"subitem_1551255818386": "jpn"}]}, "item_1617186920753": {"attribute_name": "Source Identifier", "attribute_value_mlt": [{"subitem_1522646500366": "ISSN", "subitem_1522646572813": "0285-9270"}, {"subitem_1522646500366": "NCID", "subitem_1522646572813": "AN00250763"}]}, "item_1617186941041": {"attribute_name": "Source Title", "attribute_value_mlt": [{"subitem_1522650068558": "ja", "subitem_1522650091861": "琉球大学保健学医学雑誌=Ryukyu University Journal of Health Sciences and Medicine"}]}, "item_1617187056579": {"attribute_name": "Bibliographic Information", "attribute_value_mlt": [{"bibliographicIssueNumber": "2", "bibliographicPageEnd": "147", "bibliographicPageStart": "141", "bibliographicVolumeNumber": "3"}]}, "item_1617258105262": {"attribute_name": "Resource Type", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_1617265215918": {"attribute_name": "Version Type", "attribute_value_mlt": [{"subitem_1522305645492": "VoR", "subitem_1600292170262": "http://purl.org/coar/version/c_970fb48d4fbd8a85"}]}, "item_1617605131499": {"attribute_name": "File", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "download_preview_message": "", "file_order": 0, "filename": "v3p141.pdf", "future_date_message": "", "is_thumbnail": false, "mimetype": "", "size": 0, "url": {"objectType": "fulltext", "url": "https://u-ryukyu.repo.nii.ac.jp/record/2016290/files/v3p141.pdf"}, "version_id": "f4458cf4-2f9f-4134-97eb-21b5f2cff18d"}]}, "item_title": "[原著]SLE の血液透析療法", "item_type_id": "15", "owner": "1", "path": ["1642838247989", "1642838412624"], "permalink_uri": "http://hdl.handle.net/20.500.12000/0002016290", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2014-07-18"}, "publish_date": "2014-07-18", "publish_status": "0", "recid": "2016290", "relation": {}, "relation_version_is_last": true, "title": ["[原著]SLE の血液透析療法"], "weko_shared_id": -1}
  1. 学術雑誌論文
  2. 琉球医学会
  3. 琉球大学保健学医学雑誌
  4. 3巻2号
  1. 部局別インデックス
  2. その他

[原著]SLE の血液透析療法

http://hdl.handle.net/20.500.12000/0002016290
http://hdl.handle.net/20.500.12000/0002016290
18a02d3d-5ecc-42e5-89f7-94be629fa690
名前 / ファイル ライセンス アクション
v3p141.pdf v3p141.pdf
Item type デフォルトアイテムタイプ(フル)(1)
公開日 2014-07-18
タイトル
タイトル [原著]SLE の血液透析療法
言語 ja
タイトル
タイトル Hemodialysis treatment of SLE
言語 en
作成者 大浦, 孝

× 大浦, 孝

ja 大浦, 孝

Search repository
佐久本, 政紀

× 佐久本, 政紀

ja 佐久本, 政紀

Search repository
三村, 悟郎

× 三村, 悟郎

ja 三村, 悟郎

Search repository
宮里, 不二彦

× 宮里, 不二彦

ja 宮里, 不二彦

Search repository
山口, 栄豊

× 山口, 栄豊

ja 山口, 栄豊

Search repository
Oura, Takashi

× Oura, Takashi

en Oura, Takashi

Search repository
Sakumoto, Seiki

× Sakumoto, Seiki

en Sakumoto, Seiki

Search repository
Mimura, Goro

× Mimura, Goro

en Mimura, Goro

Search repository
Miyasato, Fuzihiko

× Miyasato, Fuzihiko

en Miyasato, Fuzihiko

Search repository
Yamaguchi, Eiho

× Yamaguchi, Eiho

en Yamaguchi, Eiho

Search repository
アクセス権
アクセス権 open access
アクセス権URI http://purl.org/coar/access_right/c_abf2
権利情報
言語 ja
権利情報 琉球医学会
内容記述
内容記述タイプ Other
内容記述 Dialysis treatment is developing every year and it's indication is becoming very wide. For example, now it is possible to treat chronic renal failure (CRF) due to diabetes mellitus or systemic lupus erythematosus (SLE) by hemodialysis. But there are many troubles during hemodialysis treatment of these diseases. We experienced 3 cases of SLE, which developed CRF and hemodialysis was introduced. We describe the clinical course of pre-dialysis and post-dialysis, and discuss the specific problems of SLE during hemodialysis. Case 1, 27 year old, female, the onset was at age 18, nephrotic syndrome was complicated after 7 years, then corticosteroid therapy was strted but after one year she rejected our therapy and changed to the so-called traditional vacuum therapy. Soon after she returned to our clinics, by then she was in terminal stage of disease, namely CRF and chronic heart failure. Peritoneal dialysis was strted and then maintenance hemodialysis was introduced. The clinical course of post-hemodialysis was uneventful. There were no specific problems during hemodialysis and it was possible to rehabilitate. Case 2, 19 year old, female, the onset was at age 15, nephrotic syndrome was complicated. Corticosteroid therapy was strted, but she developed CRF 4 years after the onset. Occational high fever appeared during hemodialysis, and infection was suspected. Unfortunately she died 2 months after beginning hemodialysis due to cerebro-vascular accident (CVA). Case 3, 45 year old, female, the onset was at age 31. She suffered from many complications, such as epilepsy, aseptic necrosis of femoral head and urinary tract infection. Lupus nephritis gradully progressed to CRF over 10 years. After beginning hemodialysis she suffered from G-1 bleeding and accelerated hypertension so rehavilitation was difficult until now. We discuss some problems during hemodialysis of SLE. Infection was the ploblem in case 2 and CVA was attributable to bleeding tndency, which is one of the symptoms of SLE, and may be exacervated by using heparin during hemodialysis. G-1 bleeding and accelerated hypertension were the problems in case 3. There were some problems during hemodialysis of SLE, but it is possible to control CRF due to SLE by hemodialysis such as case 1, so we should try many more case of SLE to solve these problems.
内容記述
内容記述タイプ Other
内容記述 論文
出版者
言語 ja
出版者 琉球大学保健学部
出版者
言語 en
出版者 College of Health Sciences, University of the Ryukyus
言語
言語 jpn
資源タイプ
資源タイプ journal article
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
収録物識別子
収録物識別子タイプ ISSN
収録物識別子 0285-9270
収録物識別子
収録物識別子タイプ NCID
収録物識別子 AN00250763
収録物名
言語 ja
収録物名 琉球大学保健学医学雑誌=Ryukyu University Journal of Health Sciences and Medicine
書誌情報
巻 3, 号 2, p. 141-147
戻る
0
views
See details
Views

Versions

Ver.1 2022-02-22 04:45:37.939425
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3